{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T22:43:14Z","timestamp":1722897794848},"reference-count":45,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ftd.0b013e31826ec4b4","type":"journal-article","created":{"date-parts":[[2012,9,12]],"date-time":"2012-09-12T00:37:12Z","timestamp":1347410232000},"page":"584-592","source":"Crossref","is-referenced-by-count":4,"title":["Establishment of Thiopurine S-Methyltransferase Gene Knockdown in Jurkat T-lymphocytes"],"prefix":"10.1097","volume":"34","author":[{"given":"Misbah","family":"Misdaq","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reiner","family":"Andag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Oellerich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul R.","family":"Asif","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"von Ahsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-16-20210129","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1440-1746.2005.03832.x","article-title":"Azathioprine and 6-mercaptopurine pharmacogenetics and metabolite monitoring in inflammatory bowel disease.","volume":"20","author":"Gearry","year":"2005","journal-title":"J Gastroenterol Hepatol"},{"key":"R2-16-20210129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1517\/14622416.3.1.89","article-title":"The thiopurine S-methyltransferase gene locusimplications for clinical pharmacogenomics.","volume":"3","author":"McLeod","year":"2002","journal-title":"Pharmacogenomics"},{"key":"R3-16-20210129","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrc1800","article-title":"Acute lymphoblastic leukaemia: a model for the pharmacogenomics of cancer therapy.","volume":"6","author":"Cheok","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"R4-16-20210129","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.fpc.0000114745.08559.db","article-title":". Comprehensive analysis of thiopurine S-methyltransferase phenotype-genotype correlation in a large population of German-Caucasians and identification of novel TPMT variants.","volume":"14","author":"Schaeffeler","year":"2004","journal-title":"Pharmacogenetics"},{"key":"R5-16-20210129","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1038\/sj.onc.1209372","article-title":"Thiopurine S-methyltransferase pharmacogenetics: insights, challenges and future directions.","volume":"25","author":"Wang","year":"2006","journal-title":"Oncogene"},{"key":"R6-16-20210129","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2217\/14622416.9.3.303","article-title":". Ethnic variation of thiopurine S-methyltransferase activity: a large, prospective population study.","volume":"9","author":"Cooper","year":"2008","journal-title":"Pharmacogenomics"},{"key":"R7-16-20210129","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00008571-199912000-00012","article-title":". Ethnic differences in thiopurine methyltransferase pharmacogenetics: evidence for allele specificity in Caucasian and Kenyan individuals.","volume":"9","author":"McLeod","year":"1999","journal-title":"Pharmacogenetics"},{"key":"R8-16-20210129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/clpt.2010.320","article-title":". Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing.","volume":"89","author":"Relling","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"R9-16-20210129","first-page":"721","article-title":"Evaluating frequencies of thiopurine S-methyl transferase (TPMT) variant alleles in Israeli ethnic subpopulations using DNA analysis.","volume":"12","author":"Ronen","year":"2010","journal-title":"Isr Med Assoc J"},{"key":"R10-16-20210129","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0016-5085(00)70354-4","article-title":". Genotypic analysis of thiopurine S-methyltransferase in patients with Crohns disease and severe myelosuppression during azathioprine therapy.","volume":"118","author":"Colombel","year":"2000","journal-title":"Gastroenterology"},{"key":"R11-16-20210129","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejpb.2007.10.004","article-title":". A novel gene delivery system for stable transfection of thiopurine-S-methyltransferase gene in versatile cell types.","volume":"69","author":"Egle","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"R12-16-20210129","first-page":"5810","article-title":". Differing contribution of thiopurine methyltransferase to mercaptopurine versus thioguanine effects in human leukemic cells.","volume":"61","author":"Dervieux","year":"2001","journal-title":"Cancer Res"},{"key":"R13-16-20210129","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/mol.62.1.102","article-title":". The effect of thiopurine methyltransferase expression on sensitivity to thiopurine drugs.","volume":"62","author":"Coulthard","year":"2002","journal-title":"Mol Pharmacol"},{"key":"R14-16-20210129","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1097\/00008571-200208000-00003","article-title":". Azathioprine therapy and adverse drug reactions in patients with inflammatory bowel disease: impact of thiopurine S-methyltransferase polymorphism.","volume":"12","author":"Schwab","year":"2002","journal-title":"Pharmacogenetics"},{"key":"R15-16-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1097\/FTD.0b013e31820810cd","article-title":". Systematic review of thiopurine methyltransferase genotype and enzymatic testing strategies.","volume":"33","author":"Donnan","year":"2011","journal-title":"Ther Drug Monit"},{"key":"R16-16-20210129","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.bcp.2010.01.006","article-title":"Thiopurines: factors influencing toxicity and response.","volume":"79","author":"Fotoohi","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"R17-16-20210129","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nature02872","article-title":"Revealing the world of RNA interference.","volume":"431","author":"Mello","year":"2004","journal-title":"Nature"},{"key":"R18-16-20210129","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1038\/nbt1369","article-title":"RNA interference against viruses: strike and counterstrike.","volume":"25","author":"Haasnoot","year":"2007","journal-title":"Nat Biotechnol"},{"key":"R19-16-20210129","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrd2355","article-title":". Utilizing RNA interference to enhance cancer drug discovery.","volume":"6","author":"Iorns","year":"2007","journal-title":"Nat Rev Drug Discov"},{"key":"R20-16-20210129","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1477-5956-9-71","article-title":". Fetal calf serum heat inactivation and lipopolysaccharide contamination influence the human T lymphoblast proteome and phosphoproteome.","volume":"9","author":"Rahman","year":"2011","journal-title":"Proteome Sci"},{"key":"R21-16-20210129","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1477-5956-9-57","article-title":". Differential proteome analysis of human embryonic kidney cell line (HEK-293) following mycophenolic acid treatment.","volume":"9","author":"Qasim","year":"2011","journal-title":"Proteome Sci"},{"key":"R22-16-20210129","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method.","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"key":"R23-16-20210129","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/00007691-200310000-00014","article-title":". Determination of thiopurine methyltransferase phenotype in isolated human erythrocytes using a new simple nonradioactive HPLC method.","volume":"25","author":"Indjova","year":"2003","journal-title":"Ther Drug Monit"},{"key":"R25-16-20210129","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0378-4347(92)80347-S","article-title":"High-performance liquid chromatographic assay of the methyl and nucleotide metabolites of 6-mercaptopurine: quantitation of red blood cell 6-thioguanine nucleotide, 6-thioinosinic acid and 6-methylmercaptopurine metabolites in a single sample.","volume":"583","author":"Lennard","year":"1992","journal-title":"J Chromatogr"},{"key":"R26-16-20210129","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1373\/49.2.260","article-title":". Differences in nucleotide hydrolysis contribute to the differences between erythrocyte 6-thioguanine nucleotide concentrations determined by two widely used methods.","volume":"49","author":"Shipkova","year":"2003","journal-title":"Clin Chem"},{"key":"R27-16-20210129","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nbt1052","article-title":". Synthetic shRNAs as potent RNAi triggers.","volume":"23","author":"Siolas","year":"2005","journal-title":"Nat Biotechnol"},{"key":"R28-16-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2036.2011.04905.x","article-title":". Review article: benefits of pharmacogenetics for improving thiopurine therapy in inflammatory bowel disease.","volume":"35","author":"Chouchana","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"R29-16-20210129","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1365-2036.2002.01353.x","article-title":". Thiopurine methyltransferase activity and the use of azathioprine in inflammatory bowel disease.","volume":"16","author":"Ansari","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"R30-16-20210129","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/gast.2002.32420","article-title":". 6-MP metabolite profiles provide a biochemical explanation for 6-MP resistance in patients with inflammatory bowel disease.","volume":"122","author":"Dubinsky","year":"2002","journal-title":"Gastroenterology"},{"key":"R31-16-20210129","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00007691-199608000-00003","article-title":"Individualizing therapy with 6-mercaptopurine and 6-thioguanine related to the thiopurine methyltransferase genetic polymorphism.","volume":"18","author":"Lennard","year":"1996","journal-title":"Ther Drug Monit"},{"key":"R32-16-20210129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/bioinformatics\/bti196","article-title":"Highly specific and accurate selection of siRNAs for high-throughput functional assays.","volume":"21","author":"Santoyo","year":"2005","journal-title":"Bioinformatics"},{"key":"R33-16-20210129","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1101\/gad.981002","article-title":". Short hairpin RNAs (shRNAs) induce sequence-specific silencing in mammalian cells.","volume":"16","author":"Paddison","year":"2002","journal-title":"Genes Dev"},{"key":"R34-16-20210129","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1365-2036.2007.03301.x","article-title":". Assessment of thiopurine methyltransferase enzyme activity is superior to genotype in predicting myelosuppression following azathioprine therapy in patients with inflammatory bowel disease.","volume":"25","author":"Winter","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"R35-16-20210129","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/leu.2008.316","article-title":". Thiopurine methyltransferase activity is related to the risk of relapse of childhood acute lymphoblastic leukemia: results from the NOPHO ALL-92 study.","volume":"23","author":"Schmiegelow","year":"2008","journal-title":"Leukemia"},{"key":"R36-16-20210129","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.cca.2006.07.010","article-title":". Efficient screening method of the thiopurine methyltransferase polymorphisms for patients considering taking thiopurine drugs in a Chinese Han population in Henan Province (central China).","volume":"376","author":"Zhang","year":"2007","journal-title":"Clin Chim Acta"},{"key":"R37-16-20210129","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1097\/00007691-200404000-00024","article-title":"Shipkova M, von AN, et al.. Analytic aspects of monitoring therapy with thiopurine medications.","volume":"26","author":"Armstrong","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R38-16-20210129","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1182\/blood.V85.7.1897.bloodjournal8571897","article-title":". Polymorphic thiopurine methyltransferase in erythrocytes is indicative of activity in leukemic blasts from children with acute lymphoblastic leukemia.","volume":"85","author":"McLeod","year":"1995","journal-title":"Blood"},{"key":"R39-16-20210129","doi-asserted-by":"crossref","first-page":"7403","DOI":"10.1038\/sj.onc.1206944","article-title":"Drug methylation in cancer therapy: lessons from the TPMT polymorphism.","volume":"22","author":"Krynetski","year":"2003","journal-title":"Oncogene"},{"key":"R40-16-20210129","first-page":"186","article-title":"Is 6-thioguanine more appropriate than 6-mercaptopurine for children with acute lymphoblastic leukaemia Br J Cancer.","volume":"68","author":"Lennard","year":"1993","journal-title":""},{"key":"R41-16-20210129","first-page":"RA247","article-title":". Reviewing the mechanism of action of thiopurine drugs: towards a new paradigm in clinical practice.","volume":"10","author":"Cara","year":"2004","journal-title":"Med Sci Monit"},{"key":"R42-16-20210129","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1172\/JCI16432","article-title":". CD28-dependent Rac1 activation is the molecular target of azathioprine in primary human CD4 T lymphocytes.","volume":"111","author":"Tiede","year":"2003","journal-title":"J Clin Invest"},{"key":"R43-16-20210129","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.crohns.2009.02.003","article-title":". Long term efficacy and safety of allopurinol and azathioprine or 6-mercaptopurine in patients with inflammatory bowel disease.","volume":"3","author":"Leung","year":"2009","journal-title":"J Crohns Colitis"},{"key":"R44-16-20210129","doi-asserted-by":"crossref","first-page":"4166","DOI":"10.3748\/wjg.v17.i37.4166","article-title":"Optimizing 6-mercaptopurine and azathioprine therapy in the management of inflammatory bowel disease.","volume":"17","author":"Bradford","year":"2011","journal-title":"World J Gastroenterol"},{"key":"R45-16-20210129","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1373\/clinchem.2007.086215","article-title":". 6-thioguanine nucleotide-adapted azathioprine therapy does not lead to higher remission rates than standard therapy in chronic active crohn disease: results from a randomized, controlled, open trial.","volume":"53","author":"Reinshagen","year":"2007","journal-title":"Clin Chem"},{"key":"R46-16-20210129","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/j.1365-2036.2006.02980.x","article-title":". Review article: thiopurines in inflammatory bowel disease.","volume":"24","author":"Derijks","year":"2006","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31826ec4b4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:40:08Z","timestamp":1620952808000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201210000-00016"}},"subtitle":["An In Vitro Model of TPMT Polymorphism"],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31826ec4b4","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}